Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study to Evaluate Performance of the LUM Imaging System for Intraoperative Detection of Residual Tumor in Breast Cancer Patients Receiving and Not Receiving Neoadjuvant Therapy

NCT04440982 is registered in ClinicalTrials.gov with Lumicell, Inc. as lead sponsor.

NCT NCT04440982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04440982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study to Evaluate Performance of the LUM Imaging System for Intraoperative Detection of Residual Tumor in Breast Cancer Patients Receiving and Not Receiving Neoadjuvant Therapy
Lead sponsor
Lumicell, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 1, 2020
Completion date
February 29, 2024
Enrollment
98 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoadjuvant therapy